12th EU-China Business Summit
Date
Address
Section
Event Location
Event Description
The 12th EU-China Business Summit takes place on 2 June 2017 in Brussels, Belgium. This business summit is co-organised by BusinessEurope and the China Council for the Promotion of International Trade (CCPIT), and forms the most significant business platform for discussion on the economic relationship between China and Europe. With some 500 participants from both China and Europe, the summit offers the best opportunity to meet fellow business and political leaders. This year’s programme is still under development, and this website will be updated on an ongoing basis with more information. Places are limited, so you are advised to register as early as possible. You may contact us directly with any question using the link above. We are looking forward to welcoming you at this year’s edition.
#EUChina
Venue address :
Egmont Palace
Europe Room
Petit Sablon 8 bis
1000 Brussels
EURACTIV is a Media Partner of this event.
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- Italy strongly condemns Israeli strikes in Lebanon targeting Italian bases
- Barnier’s 2025 budget heads to Parliament after ministers’ nod
- Polish support for receiving Ukrainian refugees reaches new low
- Czech food producers warn EU legislation could push up food prices
- Stop Israel from bombing Iran’s oil sites, Gulf states urge US